Home » Topics » Disease categories and therapies » Cancer

Cancer
RSS

AB Science seeking European approval for masitinib in treatment of pancreatic cancer

Oct. 17, 2012

ArQule and Daiichi Sankyo enter SPA agreement with FDA

Oct. 17, 2012

Incyte presents novel PI3Kdelta inhibitors

Oct. 17, 2012

Onyx Pharmaceuticals completes enrollment in phase III FOCUS trial

Oct. 16, 2012

Enrollment of fifth patient in ibrutinib trial triggers milestone payment

Oct. 16, 2012

FDA grants Meridian Laboratories pre-IND meeting for ML-061

Oct. 16, 2012

Eternity Bioscience patents novel PARP-1 inhibitors

Oct. 16, 2012

Specialised Therapeutics Australia in-licenses rights to anamorelin

Oct. 16, 2012

Advanced Cancer Therapeutics receives NIH grant to develop novel agent for brain cancer

Oct. 16, 2012

FDA approves Abraxane for NSCLC

Oct. 15, 2012

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 25, 2026.
Have brain-computer interfaces finally arrived?
BioWorld
More and more individuals now have chronically implanted brain-computer interface (BCI) systems in their heads. Devices that can record and stimulate neural...
News in brief
BioWorld Asia
BioWorld Asia briefs for June 23, 2026
Brain-computer interfaces are here but long road ahead
BioWorld
The field of BCI is continually evolving; as such, companies are increasingly highlighting the potential of their technologies to transform care. For advanced...
2026 marks critical turning point for BCI technology
BioWorld
Decades of research are helping unravel the “black box” of the brain. The second article in BioWorld’s series on the Brain-Computer Interface (BCI) field looks at...